IRVINE, CA–(Marketwired – Nov 28, 2017) – Cannabis Science, Inc. ( OTC PINK : CBIS), a U.S. company specializing in the development of cannabinoid -based medicines, announces that its research staff is nearing completion of a novel new cannabinoid formulary to treat the Asthma and Chronic … Read More
The post Cannabis Science, Inc. Announces the Nearing Completion of a Novel Patentable Formulary … appeared first on Dagga Magazine.